Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04838275 · ClinicalTrials.gov registry record · NA

IPF mHealth Exercise Study

A NA study of Idiopathic Pulmonary Fibrosis, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT04838275 is a NA study of Idiopathic Pulmonary Fibrosis that has completed, run by University of Washington. The registered enrollment target is 32 participants, below the 751-participant average among 51 other Idiopathic Pulmonary Fibrosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04838275, a NA study of Idiopathic Pulmonary Fibrosis, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Patients with idiopathic pulmonary fibrosis (IPF) who are stable on antifibrotic therapy at least 3 months will be randomized to complete a 12-week home exercise intervention using an mHealth platform, plus a pre- and post-intervention monitoring period (4 weeks each) and in-person study assessments.

Conditions Studied

Idiopathic Pulmonary Fibrosis

Interventions

  • BEHAVIORAL 12-week mHealth home exercise prescription

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2021-05-01
Est. Completion 2024-12-31
Phase NA

Sponsor

University of Washington

1,048 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04838275

The ClinicalTrials.gov registry entry for NCT04838275 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 751-participant average among 51 other Idiopathic Pulmonary Fibrosis trials with a reported enrollment target (96% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Idiopathic Pulmonary Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which 12-week mHealth home exercise prescription is the first listed.

NCT04838275 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04838275 about?

NCT04838275 is a clinical study titled "IPF mHealth Exercise Study". Patients with idiopathic pulmonary fibrosis (IPF) who are stable on antifibrotic therapy at least 3 months will be randomized to complete a 12-week home exercise intervention using an mHealth platform, plus a pre- and post-intervention monitoring period (4 weeks each) and in-person study assessments...

What is the current status of trial NCT04838275?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-05-01. Estimated completion is 2024-12-31.

What conditions does trial NCT04838275 study?

This clinical trial studies the following conditions: Idiopathic Pulmonary Fibrosis.

What interventions are being tested in trial NCT04838275?

The interventions under investigation include: 12-week mHealth home exercise prescription (BEHAVIORAL).

Who is sponsoring clinical trial NCT04838275?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04838275 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Idiopathic Pulmonary Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Idiopathic Pulmonary Fibrosis

All registered trials for this condition

Washington

All trials with a study site in Washington

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.